Caspase-3 activation is not responsible for vinblastine-induced Bcl-2 phosphorylation and G2/M arrest in human small cell lung carcinoma Ms-1 cells

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 940-946

  Tashiro, Etsu ^a   Simizu, Siro ^a   Takada, Minoru ^b   Umezawa, Kazuo ^a   Imoto, Masaya ^a  

^a KEIO UNIVERSITY   (Japan)

^b Department of Cardiology   (Japan)

Author keywords

Bcl 2; Caspase 3; G2 M arrest; Vinblastine

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; METAPHASE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031766694     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00652.x     Document Type: Article

References (29)

1. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H. and Wilson, L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res., 51, 2212-2222 (1991).
2. Howard, S. M. H., Theologides, A. and Sheppard, J. R. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Cancer Res., 40, 2695-2700 (1980).
3. Wendell, K. L., Wilson, L. and Jordan, M. A. Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes. J. Cell Sci., 104, 261-272 (1993).
4. Donehower, L. A. and Bradley, A. The tumor suppressor p53. Biochim. Biophys. Acta, 1155, 181-205 (1993).
5. Zambetti, G. P. and Levine, A. J. A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7, 855-865 (1993).
6. Yuan, J., Shahan, S., Lendoux, S., Ellis, H. M. and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75, 641-652 (1993).
7. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-347 (1994).
8. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L. and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43 (1995).
9. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809 (1995).
10. Hengartner, M. O. and Horvitz, H. R. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev., 4, 581-586 (1994).
11. Hengartner, M. O. and Horvitz, H. R. C. elegans cell-survival gene Ced-9 encodes a functional homolog of the mammalian protooncogene Bcl-2. Cell, 76, 665-676 (1994).
12. Chresta, C. M., Masters, J. R. W. and Hickman, J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res., 56, 1834-1841 (1996).
13. Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L. and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251 (1993).
14. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T. and Bredesen, D. E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science, 262, 1274-1277 (1993).
15. Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H. and Tsujimoto, Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene, 12, 2251-2257 (1996).
16. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ., 7, 1087-1094 (1996).
17. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res., 56, 4743-4748 (1996).
18. Guan, R. J., Khatr, B. S. and Cohlberg, J. A. Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthesis kinase 3). J. Biol. Chem., 266, 8262-8267 (1991).
19. Haldar, S., Chintapalli, J. and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56, 1253-1255 (1996).
20. Blagosklonny, M., Schulte, T., Nguyen, P., Trepe, J. and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56, 1851-1854 (1996).
21. Guan, R. J., Moss, S. F., Arber, N., Krajewsk, S., Reed, J. C. and Holt, P. R. 30 kDa phosphorylated form of Bcl-2 protein in human colon. Oncogene, 12, 2605-2609 (1996).
22. L. J. Biol. Chem., 271, 17601-17604 (1996).
23. Haldar, S., Jena, N. and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92, 4507-4511 (1995).
24. Haldar, S. Basu, A. and Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57, 229-233 (1997).
25. L overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res., 57, 1109-1115 (1997).
26. Blagosklonny, M. V., Giannakako, P., El-Deiry, W. S., Kingston, D. G. I., Higgs, P. I., Neckers, L. and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57, 130-135 (1997).
27. Ito, T., Deng, X., Carr, B. and May, W. S. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem., 272, 11671-11673 (1997).
28. Xiang, J., Chao, D. T. and Korsmeyer, S. J. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93, 14559-14563 (1996).
29. Simonian, P. L., Grillot, D. A. M., Andrews, D. W., Leber, B. and Nunez, G. Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death. J. Biol. Chem., 271, 32073-32077 (1996).